ArticleAntimicrobial agents and chemotherapy2021

A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant

Sho Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.